This Stock Just Flew 54%: Why Young Investors Should Get in Before it Jumps Again

Shares of Charlotte’s Web Holdings Inc (TSX:CWEB) have risen more than 54% since June but find out why young investors shouldn’t be feeling as though its still too late to be investing in the market’s leading CBD company.

| More on:
Simple life style relaxation with Asian working business woman healthy lifestyle take it easy resting in comfort hotel or home living room having free time with peace of mind and self health balance

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Shares of Charlotte’s Web Holdings Inc (TSX:CWEB) have soared more than 54% since the third week of June.

In this post, I’ll do my best to explain why I think that rather than feeling as though they’ve lost out, investors, and particularly younger investors, shouldn’t be too quick to pass up on the exciting opportunity to buy a stake in the market’s leading cannabidiol (“CBD”) producer.

The market for CBD is growing fast, there’s no question about it, but if you’re newer to following the market for cannabis stocks, there’s a chance that perhaps you don’t quite understand where CBD fits into to the bigger picture.

Essentially, CBD is a chemical compound, otherwise known as cannabidiol, that’s derived from the hemp plant.

For those who may not be all that familiar with hemp, it’s a plant with an extensive track record of use throughout our planet’s history, including being used by ancient Chinese and Mesopotamian civilizations, and serving as both a source of food and input to  the manufacturing process for various clothing and household items.

More recently, however, the hemp plant is being used to extract CBD, which is then used as part of a compound to treat everyday ailments such as anxiety, joint pain and headaches.

These are virtually the same applications that medicinal cannabis has been used for over the past decade or so, yet the difference with CBD is that it doesn’t carry any associated psychological side effects.

This means that in theory, users should be able to carry out their everyday lives without experiencing the feeling of being “high” or “intoxicated” unlike what one might come to expect with traditional cannabis use.

One particularly appealing application would be for younger users like Charlotte Figi, a young girl dealing with epileptic seizures whose well-being benefited significantly from the use of CBD applications and was featured in a CNN documentary that aired in August of 2013.

CWEB has been quick to move on the opportunity for CBD demand, growing its revenues by 74% last year, with 57% of those sales coming from e-commerce channels and generating a substantive 30% adjusted EBITDA margin in the process.

Today Charlotte’s Web is the number one CBD brand by market share, with over 7,000 retail locations and more than 862 acres scheduled for planting in 2019.

But with the stock up already 21% so far this year and up more than 54% since June after suffering a short-lived sell-off earlier in the spring, investors are certainly beginning to take notice of what this company is doing.

However, that doesn’t mean that you’re too late if you’re hearing about CWEB for the first time – far from it, in fact.

The market for U.S. hemp-derived CBD is expected to reach upwards of US$6 billion by 2023 versus only an estimated US$1 billion today based on research from Hemp Industry Daily.

If CWEB can do its part to secure its fair share of that market this latest spurt in its share price could prove to be only just the beginning for Foolish readers.

Making the world smarter, happier, and richer.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Phillips has no position in any of the stocks mentioned. The Motley Fool owns shares of Charlotte's Web Holdings.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »